| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 06/24/2010 | US20100160279 Azetidine Derivatives as Muscarinic Receptor Antagonists |
| 06/24/2010 | US20100158996 Ester compound and medical use thereof |
| 06/24/2010 | CA2746764A1 New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
| 06/23/2010 | EP2197832A1 Novel aryl potassium channel blockers and uses thereof |
| 06/23/2010 | CN101747250A Method for preparing 4 - acyloxo heterocyclic ketone compounds |
| 06/23/2010 | CN101747249A Method for preparing intermediate of azetidine-typed medicaments |
| 06/22/2010 | US7741316 Pharmacological uses of azetidine derivatives |
| 06/22/2010 | US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/17/2010 | US20100152156 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases |
| 06/16/2010 | CN101743223A Novel compounds as cannabinoid receptor ligands |
| 06/16/2010 | CN101735131A New salts |
| 06/15/2010 | US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2 |
| 06/10/2010 | WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 06/10/2010 | US20100144698 Substituted azetidinones |
| 06/10/2010 | CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 06/08/2010 | US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia |
| 06/08/2010 | CA2431983C Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism |
| 06/03/2010 | WO2009061652A8 Compounds which modulate the cb2 receptor |
| 06/03/2010 | US20100137273 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 06/03/2010 | US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 06/02/2010 | DE102008059772A1 Production of a special diphenylazetidinone derivative for use, e.g. as a cholesterol-reducing agent, involves acylation of an aminomethylphenyl-azetidinone compound with a long-chain mixed acid anhydride |
| 05/27/2010 | WO2010059393A1 Serotonin receptor modulators |
| 05/27/2010 | WO2010059390A1 Modulators of serotonin receptor |
| 05/27/2010 | WO2010058020A1 Novel 1 -alkyl- 3 -hydroxy- 3 -phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| 05/27/2010 | WO2010058017A1 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| 05/27/2010 | US20100130712 Adamantane derivative, resin composition using the same, and resin cured product |
| 05/27/2010 | US20100130469 2, 6-naphthridine derivatives |
| 05/27/2010 | CA2744307A1 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
| 05/25/2010 | CA2273917C 3-pyridyl enantiomers and their use as analgesics |
| 05/20/2010 | US20100125059 1-biarylazetidinone derivative |
| 05/20/2010 | US20100125058 Naphthylacetic acids |
| 05/19/2010 | EP2186800A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 05/18/2010 | US7718704 Immunosuppressant compounds and compositions |
| 05/18/2010 | US7718675 Diamino alcohols and their use as renin inhibitor |
| 05/14/2010 | WO2010053583A2 Small molecule cd4 mimetics and uses thereof |
| 05/13/2010 | US20100120661 Heterocyclic boronic acid compounds |
| 05/12/2010 | EP2183216A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 05/06/2010 | WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 05/06/2010 | US20100113643 Curatives for epoxy adhesive compositions |
| 05/06/2010 | US20100113409 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy) azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide |
| 05/05/2010 | CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 04/29/2010 | US20100105894 Cyclopropane compounds and pharmaceutical use thereof |
| 04/29/2010 | US20100105651 Antagonists of sns sodium channels |
| 04/27/2010 | US7704988 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/21/2010 | EP2176219A1 Novel compounds as cannabinoid receptor ligands |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/13/2010 | US7696234 Histamine H3 receptor agents, preparation and therapeutic uses |
| 04/13/2010 | CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/08/2010 | US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors |
| 04/08/2010 | US20100087414 Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide |
| 04/07/2010 | EP2170807A1 Spiro compounds useful as antagonists of the h1 receptor |
| 04/07/2010 | CN1872854B Antibiotic in lactam class, and prepartion method |
| 04/06/2010 | US7691843 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 04/06/2010 | US7691841 Azetidine derivatives as CCR-3 receptor antagonist |
| 04/01/2010 | WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 03/31/2010 | EP1807393B1 Diarylsulfones as 5-ht2a antagonists |
| 03/31/2010 | CN101687769A Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoate |
| 03/31/2010 | CN101684084A Tetracycline compounds containing carbamido |
| 03/31/2010 | CN101684083A Guanidinoalkanoylamino substituted tetracycline derivatives |
| 03/30/2010 | US7687491 Immunosuppressants with low toxicity; 1-({4-Methyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl}methyl)azetidine-3-carboxylic acid for example; autoimmune diseases and transplant rejection; N-substituted azetidine, pyrrolidine or piperidine compounds |
| 03/25/2010 | US20100075946 Novel thiophene derivatives |
| 03/25/2010 | US20100075943 1-adamantylazetidin-2-one derivatives and drugs containing same |
| 03/24/2010 | CN101679236A Process for the preparation of ezetimibe and derivatives thereof |
| 03/24/2010 | CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists |
| 03/24/2010 | CN101676263A Method for synthesizing N-tert-butoxycarbonyl group-3-hydroxy azetidine |
| 03/18/2010 | US20100069347 Heterocyclyl-substituted anti-hypercholesterolemic compounds |
| 03/17/2010 | EP1347955B1 New mandelic acid derivatives and their use as throbin inhibitors |
| 03/17/2010 | CN101675031A Process for stereoselective preparation of 4-bma using a chiral auxiliary |
| 03/16/2010 | US7678904 or to treat autoimmune and inflammatory disorders; improved water solubility characteristics |
| 03/11/2010 | WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 03/09/2010 | US7674786 4-phenyl-N-substituted azetidin-2-ones; selective prostaglandin EP2 agonists; glaucoma or ocular hypertension |
| 03/09/2010 | US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels |
| 03/04/2010 | WO2010023931A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same |
| 03/04/2010 | WO2010023448A1 Novel potassium channel blockers |
| 03/04/2010 | US20100056490 Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors |
| 03/04/2010 | US20100056478 Useful Combinations of Monobactam Antibiotics With Beta-Lactamase Inhibitors |
| 03/03/2010 | CN101663270A Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 03/02/2010 | US7671047 Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/25/2010 | WO2009110985A3 Amide compounds, compositions and uses thereof |
| 02/25/2010 | US20100048530 New 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 02/24/2010 | EP2155667A1 Reduction processes for the preparation of ezetimibe |
| 02/24/2010 | EP2155666A1 Azetidine derivatives and their use as prostaglandin e2 antagonists |
| 02/16/2010 | US7662810 2-arylmethylazetidine carbapenem derivatives and preparation thereof |
| 02/16/2010 | CA2438961C Beta-lactam compounds, manufacturing methods of the compounds and serum hypocholesterolemic agents containing the compounds |
| 02/11/2010 | WO2010017470A1 C7-fluoro substituted tetracycline compounds |
| 02/11/2010 | WO2010015816A2 Treatment of lysosomal storage disorders and other proteostatic diseases |
| 02/11/2010 | US20100035857 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis |
| 02/11/2010 | CA2732883A1 C7-fluoro substituted tetracycline compounds |
| 02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2010 | WO2010012775A1 Process for the synthesis of ezetimibe and intermediates useful therefor |
| 02/04/2010 | US20100029609 Biaryl sulfonamide derivatives |
| 02/04/2010 | CA2731924A1 Process for the synthesis of ezetimibe and intermediates useful therefor |
| 02/03/2010 | EP2149547A1 Process for the synthesis of ezetimibe and intermediates useful therefor |